When to Choose
Aura-E™?
Women with hormone-related conditions like PCOS or endometriosis, unusual bleeding after menopause, a family history of cancer, or those needing regular health checks during treatment.
Aura-E™ Non-Invasive Health cars journey for Endomaterial Cancer Screening
Step 01
Order my testOrder your non-invasive kit online or through your provider. You’ll receive an activation ID for tracking and secure results access.
Step 02
Self-CollectionUse the provided brush or swab to collect cervical cells. Follow the instructions for a quick, easy, at-home process.
Step 03
Drop-off SampleDrop off the sample at a diagnostic facility or return it using the provided packaging.
Step 04
Laboratory TestingYour sample will be analyzed for cervical cancer and other abnormalities.
Why Aura-E™? is a Game-Changing
Non-Invasive Sample Collection:
Uses exfoliated cervical cells; no need for tissue biopsy at screening stage.
Early Detection of EIN+:
Supports conservative management of EIN (Endometrial Intraepithelial Neoplasia).
DNA Methylation-Based Assay:
Targets clinically validated markers (CDO1 and CELF4) for high sensitivity and specificity.
High Clinical Accuracy:
Ideal for monitoring recurrence after treatment.
88.00%
92.00%
EIN+
Efficient Triage Tool:
Detects early changes without invasive procedures like hysteroscopy .
CE-IVD Certified:
Approved for clinical use.
Endometrial Cancer
Benign Detection Rate
Clinical Trial Insights
Multi-center clinical trial with over 7,000 patients has shown that CDO1 and CELF4 methylation detection for endometrial cancer is significantly more effective than other methods.
What You Receive
Results Online
Access your test results securely via our portal using your activation ID.
Gynecology Consultation
Get a personalized consultation with a gynecologist to discuss your results and next steps.
Further Screening or Treatment
If needed, you’ll receive recommendations for additional screening or treatment.
